Askanase, A. D., Tang, W., Zuraw, Q., Gordon, R., Brotherton, B., & Merrill, J. T. (2023). Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE. Lupus Science & Medicine, 10(1), e000875. https://doi.org/10.1136/lupus-2022-000875

Forss, A., Clements, M., Myrelid, P., Strid, H., Söderman, C., Wagner, A., Andersson, D., Hjelm, F., Olén, O., Halfvarson, J., & Ludvigsson, J. F. (2022). Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn’s Disease. Digestive Diseases and Sciences, 68(1), 65–76. https://doi.org/10.1007/s10620-022-07501-z